Literature DB >> 27913485

Congenital and acquired bleeding disorders in pregnancy.

Terry B Gernsheimer1.   

Abstract

Obstetrical hematology represents challenges not only for the patient, but also for her progeny. In particular, bleeding disorders, both congenital and acquired, not only present problems both for delivery and in the immediate postpartum period, but also may have significant implications for the fetus and neonate. Women with congenital bleeding disorders or who are carriers of X-linked or autosomal disorders should be counseled prior to conception so that pregnancy can be safely undertaken with careful preparation. A treatment plan should be set up by a specialized care team that includes the hematologist, obstetrician, and anesthesiologist; the patient should be followed closely during pregnancy, through delivery, and in the immediate postpartum period. Acquired disorders of hemostasis that occur with pregnancy may present particular diagnostic difficulties and require rapid diagnosis and management.
© 2016 by The American Society of Hematology. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27913485      PMCID: PMC6142506          DOI: 10.1182/asheducation-2016.1.232

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  38 in total

Review 1.  Coagulation factor deficiencies and pregnancy loss.

Authors:  Aida Inbal; Laszlo Muszbek
Journal:  Semin Thromb Hemost       Date:  2003-04       Impact factor: 4.180

2.  Pregnancy in women with different types of von Willebrand disease.

Authors:  M Conti; D Mari; E Conti; M L Muggiasca; P M Mannucci
Journal:  Obstet Gynecol       Date:  1986-08       Impact factor: 7.661

3.  The use of fresh frozen plasma for reproduction in severe factor V deficiency.

Authors:  A A Rouzi; M H Qari; M S M Ardawi
Journal:  Clin Exp Obstet Gynecol       Date:  2015       Impact factor: 0.146

4.  Severe gestational (incidental) thrombocytopenia: to treat or not to treat.

Authors:  N Win; M Rowley; C Pollard; J Beard; H Hambley; M Booker
Journal:  Hematology       Date:  2005-02       Impact factor: 2.269

5.  Analysis of 65 pregnancies in 34 women with five different forms of inherited platelet function disorders.

Authors:  Elisa Civaschi; Catherine Klersy; Federica Melazzini; Nuria Pujol-Moix; Cristina Santoro; Marco Cattaneo; Cécile Lavenu-Bombled; Loredana Bury; Pietro Minuz; Paquita Nurden; Ana R Cid; Adam Cuker; Véronique Latger-Cannard; Remi Favier; Ilaria Nichele; Patrizia Noris
Journal:  Br J Haematol       Date:  2015-04-21       Impact factor: 6.998

Review 6.  How I treat thrombocytopenia in pregnancy.

Authors:  Terry Gernsheimer; Andra H James; Roberto Stasi
Journal:  Blood       Date:  2012-11-13       Impact factor: 22.113

7.  Prophylactic treatment of hereditary severe factor VII deficiency in pregnancy.

Authors:  Christian Pfrepper; Annelie Siegemund; Sven Hildebrandt; Juliane Kronberg; Ute Scholz; Dietger Niederwieser
Journal:  Blood Coagul Fibrinolysis       Date:  2017-09       Impact factor: 1.276

Review 8.  Management of pregnancy, labour and delivery in women with inherited bleeding disorders.

Authors:  F Y Huq; R A Kadir
Journal:  Haemophilia       Date:  2011-07       Impact factor: 4.287

9.  Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease.

Authors:  M Lak; F Peyvandi; P M Mannucci
Journal:  Br J Haematol       Date:  2000-12       Impact factor: 6.998

10.  Fetal thrombocytopenia and its relation to maternal thrombocytopenia.

Authors:  R F Burrows; J G Kelton
Journal:  N Engl J Med       Date:  1993-11-11       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.